Eli Lilly is a drug firm with a focus on neuroscience, cardiometabolic, cancer, and immunology. Lilly's key products include Verzenio for cancer; Mounjaro, Zepbound, Jardiance, Trulicity, Humalog, and ...

The FDA confirmed on Thursday that Eli Lilly’s tirzepatide, marketed as Zepbound for weight loss, is no longer in shortage, multiple outlets reported. The agency added that it will give compounders 60 ...

The Integrated Nanosystems Development Institute at Indiana University’s Innovation Hall. $138 million to the Indiana University Foundation to establish the IU Launch Accelerator for Biosciences, ...

Haringey Council began an 18-month scheme with e-bike operators Lime and Forest back in March. Now, Enfield Council has agreed to allow the trial to be extended into its boundary, marking the ...

Eli Lilly (NYSE: LLY) and Novo Nordisk (NYSE: NVO) have competed for decades. They're both leaders in the areas of insulin and broader diabetes drugs, where they've made significant breakthroughs ...

Eli Lilly and Co (Lilly) is a healthcare company that discovers, develops, and markets human healthcare products. The company offers medicines for cardiovascular conditions, diabetes, endocrinology, ...

In this article, we are going to take a look at where Eli Lilly and Company (NYSE:LLY) stands against other best safe stocks to buy according to analysts. Statistically, November and December tend ...

Also Read: What’s Going On With Eli Lilly Stock On Tuesday? Imlunestrant in combination with Eli Lilly’s Verzenio (abemaciclib) reduced the risk of progression or death by 43% versus ...

Melissa and Matthew Heald, both 31, relocated more than 500km from Gladstone to South Brisbane before welcoming identical twin girls, Lucy and Lilly, on September 6 at Mater Mothers’ Hospital.

(Bloomberg) -- Eli Lilly & Co. will begin studies to see if its blockbuster weight-loss medicines are also effective at controlling addictive behaviors like alcohol abuse, smoking and drug addiction, ...

Eli Lilly (LLY) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near term.